The Europe clinical trials market offers growth opportunities through a strong regulatory framework and rising R&D ...

The clinical trials market is ripe with opportunities due to rising chronic and rare diseases, advancements in precision ...

The market presents opportunities in expanding recruitment technologies and AI-driven solutions, emphasizing patient ...

Growth supported by increasing biopharmaceutical innovation, decentralized trial models, and expanding global patient recruitment.Austin, Texas, Jan. 15, 2026 (GLOBE NEWSWIRE) -- Clinical Trials ...

Please provide your email address to receive an email when new articles are posted on . Use of decentralized elements in cancer clinical trials did not have long-term negative effects on data quality.

Digital health technologies are transforming respiratory medicine, enhancing home monitoring and enabling decentralized clinical trials in resource-limited settings. The Panacea framework evaluates ...

As the world becomes more digital, clinical research is evolving. One major change is the rise of decentralized clinical trials, or DCTs. Unlike traditional trials that require participants to visit ...

Over the past few years, we’ve seen a wave of digital innovation in clinical trials: decentralized models, eConsent, real-time monitoring and direct-to-patient logistics. We’ve digitized nearly every ...

Thread, a North Carolina startup focused on decentralized clinical research tech, announced its purchase of voice-powered research company inVibe for an undisclosed sum. inVibe uses machine learning ...

Understand which barriers to cancer trial participation remain most difficult to overcome, including geography and trial ...

TTHealthWatch is a weekly podcast from Texas Tech. In it, Elizabeth Tracey, director of electronic media for Johns Hopkins Medicine in Baltimore, and Rick Lange, MD, president of Texas Tech Health El ...